A battle for publication In February 2026, a peer-reviewed journal finally published a case study exploring a potential link between mRNA COVID-19 vaccines and blood cancers. For the authors, however, the two-year struggle to get their research into print—alleging widespread rejection by journals unwilling to challenge the mainstream narrative—may be […] The post The unpublished risk: Scientific censorship and lingering questions on mRNA vaccines appeared first on Activist Post.
Author: Editor
